C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of Myelodysplastic Syndrome

Friday, May 28, 2021

Antengene Corporation Limited a leading innovative biopharmaceutical company dedicated to discovering developing and commercializing global firstinclass andor bestinclass therapeutics in hematology and oncology today announced the dosing of the first...

Seelos Therapeutics Receives European Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic LateralSclerosis (ALS)

Friday, May 28, 2021

Seelos Therapeutics Inc a clinicalstage biopharmaceutical company focused on thedevelopment of therapies for central nervous system disorders and rare diseases today announced it has received European OrphanDrug Designation for SLS in amyotrophic lat...

BioInvent and Transgene receive IND approval from the U.S. FDA for BT-001, a novel oncolytic virus for the treatment of solid tumors

Thursday, May 27, 2021

BioInvent International AB a biotech company focused on the discovery and development of novel and firstinclass immunemodulatory antibodies for cancer immunotherapy and Transgene Euronext Paris TNG a biotech company that designs and develops virusbas...

Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

Thursday, May 27, 2021

Menarini Silicon Biosystems a pioneer of liquid biopsy and single cell technologies announced today the launch of the new highly automated DEPArray PLUS now available with fluorescent channels This robust imagebased cellsorting technology combines m...

Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases

Wednesday, May 26, 2021

Alloy Therapeutics and Pyxis Oncology announced the formation of a joint venture named Kyma Therapeutics to develop immunemodulating antibodies for novel targets in cancer and autoimmune diseases Kyma Therapeutics will advance programs directed to im...

Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity with New Multi-Purpose Fill Suite

Wednesday, May 26, 2021

Ajinomoto BioPharma Services a leading provider of biopharmaceutical contract development and manufacturing services today announced it will soon open a high speed multipurpose fill finish line in its stateoftheart commercial manufacturing facility l...

Boehringer Ingelheim's Investigational Treatment for Cognitive Impairment Associated with Schizophrenia Receives FDA Breakthrough Therapy Designation

Tuesday, May 25, 2021

Boehringer Ingelheim today announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD for BI for the treatment of Cognitive Impairment Associated with Schizophrenia CIAS The company also announced the pla...

Dorian and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

Tuesday, May 25, 2021

Shanghai Stock Exchange listed company HitGen Inc HitGen today announced that it has entered into a research collaboration agreement with Dorian Therapeutics Inc Dorian a private biotechnology company developing senoblockers a new class of therapeuti...

Libtayo® (cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers

Monday, May 24, 2021

Regeneron Pharmaceuticals Inc and Sanofi today announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has adopted positive opinions for Libtayo cemiplimab as monotherapy in two advanced cancers The CHMP...

Liminal BioSciences Announces Closing of Divestiture of Plasma Collection Centers and Enters into Option Agreement with Kedrion

Saturday, May 22, 2021

Liminal BioSciences Inc a clinicalstage biopharmaceutical company announced today that it has closed on the previously announced divestment of its plasma collection centers Prometic Plasma Resources Inc and Prometic Plasma Resources USA Inc collecti...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations